ProCE Banner Activity

Optimizing Frontline Treatment for MCL: Considerations for BTK Inhibitors in Younger, Fit Patients

Slideset

Download these slides for more information about treatment considerations for younger, fit patients with mantle cell lymphoma, with a focus on up-to-date data on integrating BTKi into frontline therapy.

Released: December 05, 2024

Expiration: December 04, 2025

Share

Faculty

Julie M. Vose

Julie M. Vose, MD, MBA

Payne Presidential Chair
Chief, Division of Hematology/Oncology
University of Nebraska Medical Center
Buffett Cancer Center
Omaha, Nebraska

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca